Prescient Therapeutics' PTX-100 wins EMA orphan drug status for CTCL

By Proactive Investors / November 19, 2025 / www.youtube.com / Article Link

Prescient Therapeutics Ltd CEO James McDonnell talked with Proactive about the company securing Orphan Drug Designation ...

Recent News

Bank of Japan boosts rates, continuing an unwinding carry trade

December 22, 2025 / www.canadianminingreport.com

Gold stocks outperform equity market slide

December 22, 2025 / www.canadianminingreport.com

Silver inventories rebound in UK, output from major producers rises

December 15, 2025 / www.canadianminingreport.com

Silver's three-month outperformance continues

December 15, 2025 / www.canadianminingreport.com

Silver & Copper Supply Distortions Continue

December 08, 2025 / www.canadianminingreport.com

See all >